Efficacy of zoledronic acid following PLIF in patients with osteoporosis
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion
Osteoporos Int. 2016 Apr;27(4):1469-7679 patients with osteoporosis scheduled for instrumented posterior lumbar interbody fusion due to single-level degenerative spondylolisthesis were randomized to be postoperatively administered either zoledronic acid or saline. The purpose of this study was to compare groups based on fusion status, the incidence of a subsequent vertebral compression fracture, clinical outcome, serum biomarkers of bone metabolism, and femoral neck bone mineral density over the first year after surgery. Results demonstrated a higher rate of complete or partial fusion at 3, 6, and 9 months in the ZOL group compared to the control group. The incidence of subsequent VCF was 0% in the ZOL group and 17% in the control group. Significant differences in favour of the ZOL group compared to the control group were also observed for disability scores at 9 and 12 months, as well as bone resorption, formation biomarkers and femoral neck BMD throughout follow-up.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
